The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: A comparison with ultrasound

European Review for Medical and Pharmacological Sciences

Volumn 10, Issue 1, 2006, Pages 17-22

  Orlando, A ^a   Modesto, I ^a   Castiglione, F ^b   Scala, L ^a   Scimeca, D ^a   Rispo, A ^b   Teresi, S ^c   Mocciaro, F ^a   Criscuoli, V ^a   Marrone, C ^a   Platania, P ^a   De Falco, T ^b   Maisano, S ^a   Nicoli, N ^a   Cottone, M ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Di Cristina Hospital   (Italy)

Author keywords

Calprotectin; Crohn's disease; Recurrence; Ultrasound

Indexed keywords

BIOLOGICAL MARKER; CALPROTECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FECES ANALYSIS; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RELAPSE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COLONOSCOPY; CROHN DISEASE; FECES; FEMALE; HUMANS; ILEUM; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 33644529742     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Saverymuttu SH. Clinical remission in Crohn's disease: assessment using faecal Indium-111 granulocyte excretion. Digestion 1986; 33: 74-79.
2. Lauritsen K, Lauresen LS, Bukhave K, Rask Madsen J. Use of colonic eicosanoid concentrations as predictor of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment. Gut 1988; 29: 1316-1321.
3. Wright JP, Young GO, Tgler Wybrandi N. Predictor of acute relapse of Crohn's disease. A laboratory and clinical study. Dig Dis Sci 1987; 32: 164-170.
4. Kjeldsen J, Lauritsen K, de Muckadell OB. Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with active inflammatory bowel disease? Scand J Gastroenterol 1997; 32: 933-941.
5. Brignola C, Iannone P, Bellou C, de Simone G, Bassein L, Gionchetti P, et al. Prediction of relapse in patients with Crohn's disease in remission: a simplified index using laboratory tests, enhanced by clinical characteristics. Eur J Gastroenterol Hepatol 1994; 6: 955-961.
6. Wyatt J, Vogelsang H, Hubi W, Waldhoer T Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437-1439.
7. Teahon K, Smethurst P, MacPherson AJ. Intestinal permeability in Crohn's disease and its relation to disease activity and relapse following treatment with elemental diet. Eur J Gastroenterol Hepatol 1993; 5: 79-84.
8. Hilsden RJ, Meddings JB, Hardin J, Gall DG, Sutherland LR. Intestinal permeability and post-heparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis 1999; 5: 85-91.
9. SAVERYMUTTU SH, PETERS AM, CROFFON ME. Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut 1985; 26: 955-960.
10. Saverymuttu SH, Peters AM, Lavender JP. Indium autologous leucocytes in inflammatory bowel disease. Gut 1983; 24: 293-299.
11. Saverymuttu SH, Peters AM, Lavender JP. Quantitative faecal indium-111 labelled leucocyte excretion in assessment of disease activity in Crohn's disease. Gastroenterology 1983; 85: 1333-1339.
12. Dale IBP, Fagerhol MK, Scott H. Distribution of a new melomonocytic antigen (L1) in human peripheral blood leucocytes. Am J Clin Pathol 1985; 84: 24-34.
13. Fagerhol MK, Anderson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith, VL DJ. Ed. Stimulus response coupling: the role of intracellular calcium-binding p'roteins. CRC Press, pp 187-210, 1990.
14. Roseth AG, Fagerhol MK, Aadland E. Schjonsby H. Assesment of the neutrofil dominating protein calprotectin in feces. A methodologyc study. SGand J Gastroenterol 1992; 27: 793-798.
15. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997; 50 (Suppl 3): 113-123.
16. -binding proteins MRP8/14 in Crohn's disease. Digestion 1995; 56: 406-414.
17. Costa F Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as a non-invasive marker of intestinal inflammation. Dig Liver Dis 2003; 35: 642-647.
18. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assesment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58: 176-180.
19. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34: 793-798.
20. Tibble JA, Teahon K, Thjodleifsson B, Roseth AG, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506-513.
21. Roseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004; 39: 1017-1020.
22. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 15-22.
23. di Candio G, Mosca F, Campatelli A, Bianchini M, D'Ella F, Dellagiovampaola C. Sonographic detection of postsurgical recurrence of Crohn's disease. Am J Roentgenol 1986; 146: 523-526.
24. Andreoli A, Cerro P, Falasco G, Giglio LA, Prantera C. Role of ultrasonography in the diagnosis of postsurgical reccurrence Crohn's disease. Am J Gastroenterol 1998; 93: 1117-1121.
25. Ton H, Brandsnes O, Dale S. Improved assay for faecal calprotectin. Clin Chem Acta 2000; 292: 41-54
26. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, Scalici C, et al. Diagnostic accuracy of faecal Calprotectin assay in distinguish organic causes of chronic diarrea from irritable bowel sindrome: a prospective study in adults and children. Clin Chem 2003; 49: 861-867.
27. Sonneberg A, Erkernbrecht J, Peter P, et al. Detection of Crohn's disease by ultrasound. Gastroenterology 1982; 83: 430-434.
28. Sheridan MB, Nicholson DA, Martin DF. Transabdominal ultrasonography as the primary investigation in patients with suspected Crohn's disease or recurrence; A prospective study. Clin Radiol 1993; 48: 402-404.
29. Rutgeerts P Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the post-operative course of Crohn's disease. Gastroenterology 1990; 99: 956-963.
30. Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005; 54: 364-368.
31. D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 1998; 112: 419-420.
32. Ardizzone A, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004; 127: 730-740.
33. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptourine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127: 723-729.